What is the official website of Adelphi Group ?

The official website of Adelphi Group is http://www.adelphigroup.com.

What is Adelphi Group's cybersecurity risk score?

Adelphi Group has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Adelphi Group experienced?

According to Rankiteo, Adelphi Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Adelphi Group been affected by any supply chain cyber incidents ?

According to Rankiteo, Adelphi Group has been affected by a supply chain cyber incident involving Snowflake, with the incident ID ATT1764820523.

Does Adelphi Group have SOC 2 Type 1 certification ?

According to Rankiteo, Adelphi Group is not certified under SOC 2 Type 1.

Does Adelphi Group have SOC 2 Type 2 certification ?

According to Rankiteo, Adelphi Group does not hold a SOC 2 Type 2 certification.

Does Adelphi Group comply with GDPR ?

According to Rankiteo, Adelphi Group is not listed as GDPR compliant.

Does Adelphi Group have PCI DSS certification ?

According to Rankiteo, Adelphi Group does not currently maintain PCI DSS compliance.

Does Adelphi Group comply with HIPAA ?

According to Rankiteo, Adelphi Group is not compliant with HIPAA regulations.

Does Adelphi Group have ISO 27001 certification ?

According to Rankiteo,Adelphi Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Adelphi Group operate in ?

Adelphi Group operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Adelphi Group have ?

Adelphi Group employs approximately 258 people worldwide.

Does Adelphi Group own any subsidiaries ?

Adelphi Group presently has no subsidiaries across any sectors.

How many LinkedIn followers does Adelphi Group have ?

Adelphi Group's official LinkedIn profile has approximately 7,326 followers.

What is the NAICS classification code for Adelphi Group ?

Adelphi Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Adelphi Group have a Crunchbase profile ?

No, Adelphi Group does not have a profile on Crunchbase.

Does Adelphi Group have a LinkedIn profile ?

Yes, Adelphi Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/adelphi-group.

How many cybersecurity incidents has Adelphi Group experienced ?

As of June 10, 2026, Rankiteo reports that Adelphi Group has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Adelphi Group have ?

Adelphi Group has an estimated 5,683 peer or competitor companies worldwide.

What types of cybersecurity incidents has Adelphi Group faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Adelphi Group

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Adelphi Group Vendor Cyber Rating & Cyber Score

adelphigroup.com

Add Your Compliance Badge

The Adelphi Group provides a wide range of strategic support services and consulting for global pharmaceutical clients. Adelphi is dedicated to the healthcare sector, providing services across strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product development consultancy. Headquarters are located in Manchester, UK and New York with network offices throughout Europe and the US. The Adelphi Group employs over 700 people worldwide.

Adelphi Group A.I CyberSecurity Scoring

Scoring History

Adelphi Group

Adelphi Group CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Omnicom

Breach

1/2024

Snowflake

ATT1764820523

Loading…

A.I.

Adelphi Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Adelphi Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Adelphi Group in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Adelphi Group in 2026.

Incident Types Adelphi Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Adelphi Group in 2026.

Incident History - Adelphi Group (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Adelphi Group Subsidiaries

Adelphi Group

Pharmaceutical Manufacturing

Website: http://www.adelphigroup.com

Company Size: 258

Omnicom HealthMarketing Services

Healthcare Consultancy Group - HCGAdvertising Services

BioluminaAdvertising Services

OmnicomAdvertising Services

Omnicom AdvertisingAdvertising Services

FlywheelAdvertising Services

Omnicom ProductionAdvertising Services

Omnicom PR Group (OPRG)Public Relations and Communications Services

Omnicom Precision Marketing GroupAdvertising Services

Omnicom Specialty Marketing GroupAdvertising Services

Harrison/StarAdvertising Services

DDB Health New YorkAdvertising Services

2TN (2 the Nth)Pharmaceutical Manufacturing

Ology Medical EducationWellness and Fitness Services

Adelphi AccessPharmaceutical Manufacturing

DDB Remedy LondonAdvertising Services

Archbow ConsultingPharmaceutical Manufacturing

The Planning ShopAdvertising Services

Excerpta Medica BV - Adelphi GroupPharmaceutical Manufacturing

Adelphi Real WorldBusiness Consulting and Services

Science & PurposeAdvertising Services

MCIMarket Research

DDB Health BarcelonaAdvertising Services

cdmpAdvertising Services

SSCG Media GroupAdvertising Services

Addressable HealthAdvertising Services

Wildtype HealthAdvertising Services

PROPELLERAdvertising Services

BioPharm CommunicationsAdvertising Services

Expert Perspectives by Engage Health MediaPharmaceutical Manufacturing

TBWA\WORLDHEALTHAdvertising Services

CDM BarcelonaAdvertising Services

Loading…

Adelphi Group Similar Companies

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

EMS

cb ems.com.br

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os maiores laboratórios em preferência prescritiva no Brasil. Tem forte presença em PDVs de todo o país e atuação nas áreas de Prescrição Médica, Genéricos, Marcas, OTC e Hospitalar, fabricando medicamentos para praticamente todas as especialidades da Medicina. Possui fábricas em Hortolândia (SP), Manaus (AM), Brasília (DF) e Jaguariúna (SP). A EMS apoia ações de responsabilidade social dentro e fora do Brasil. Em 2017, por exemplo, o laboratório fechou parceria com a Organização Mundial da Saúde (OMS) para doar 100% do medicamento para erradicar, nos próximos anos, em todo o planeta, a bouba, doença negligenciada. A EMS é a única farmacêutica no mundo a ter abraçado essa causa. O Centro de Pesquisa & Desenvolvimento da EMS no Brasil é o mais moderno da América Latina. Na Itália, a EMS tem o laboratório de pesquisas MonteResearch. O foco de atuação do laboratório é a inovação nas seguintes frentes: inovação incremental; genéricos de alta complexidade; medicamentos biotecnológicos, por meio da empresa Bionovis; e inovação disruptiva, por meio da Brace Pharma, empresa da EMS instalada em 2013 nos Estados Unidos. Ainda, nos EUA, por meio de sua controlada Vero Biotech, localizada em Atlanta, Geórgia, a EMS, recentemente, obteve a aprovação de seu primeiro produto revolucionário submetido à FDA (Food and Drug Administration), posicionando o laboratório como uma empresa de inovação no mercado global. Com aportes frequentes em infraestrutura fabril e em pesquisa de ponta para desenvolver produtos inovadores, eficazes e seguros, a EMS, que já exporta para mais de 40 países, está preparada para continuar cuidando das pessoas que querem viver cada vez mais e melhor.

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Adelphi Group CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 10, 2026 08:00 AM

Student accused of AI plagiarism wins lawsuit against Adelphi University

After being accused of cheating, a student sued his university and won. He denied ever having cheating on his essay.

Read Article

November 21, 2024 08:00 AM

Introduction: Attacking the issue

The exciting and ingenious advances we will continue to make in digital technology in the coming decades will revolutionise the way we live...

Read Article

June 22, 2023 07:00 AM

List of victimized companies of MOVEit Cyber Attack

The companies affected by the Move It cyber attack. Stay informed about the latest cybersecurity threats and protect your organization from...

Read Article

May 05, 2020 07:00 AM

Army project aligns data visualization with mental models of cyber defenders

ADELPHI, Md. -- A new data visualization approach developed by researchers working on an Army project may help cybersecurity experts detect,...

Read Article

November 17, 2018 08:00 AM

EY bolsters Advisory practice in Oceania with Adelphi Digital acquisition

Professional services firm EY has acquired Adelphi Digital Consulting Group, a digital consultancy with around 170 employees based in Australia, Singapore and...

Read Article

November 17, 2018 08:00 AM

EY buys Adelphi, adds 170 staff in Australia, Singapore and Thailand

EY, one of the globe's four largest accounting and consulting groups, has beefed up its digital consultancy offering in Asia Pacific (APAC)...

Read Article

September 06, 2018 07:00 AM

Army research takes proactive approach to defending computer systems

ADELPHI, Md. -- A team of researchers from the U.S. Army Research Laboratory, the University of Canterbury in New Zealand and the Gwangju...

Read Article

August 26, 2018 07:00 AM

Evita Almassi, Christopher Main (Published 2018)

The bride, a digital marketing and communications manager, and the groom, a cybersecurity analyst, met through OkCupid in 2014.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-9754

SUMMARY

An authenticated user with the read role may read limited amounts of uninitialized stack memory via specially-crafted issuances of the filemd5 command

Published

Date2026-06-09

Updated

Date2026-06-09

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://jira.mongodb.org/browse/SERVER-122207

CVE-2026-9753

SUMMARY

The $_internalApplyOplogUpdate aggregation pipeline stage can be used to execute a document diff containing a malformed binary diff to return memory out-of-bounds or crash the server. $_internalApplyOplogUpdate can be executed by any authenticated user with access to the aggregate command.

Published

Date2026-06-09

Updated

Date2026-06-09

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:H

cvss4

Base Score: 7.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.8

REFERENCES

https://jira.mongodb.org/browse/SERVER-124959

CVE-2026-9752

SUMMARY

An authorized user could trigger a server crash by running a query with a 2dsphere index on a field that stores a GeoJSON GeometryCollection containing a Polygon with a strict-winding CRS. Strict-winding polygons are intentionally unsupported for indexing, but the guard that rejects them does not inspect members of a GeometryCollection, allowing the unsafe path to be reached which ends with an ensuing null-pointer dereference.

Published

Date2026-06-09

Updated

Date2026-06-09

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://jira.mongodb.org/browse/SERVER-123440

CVE-2026-9751

SUMMARY

The ldapQueryPassword parameter, when set through the runtime setParameter command, will log the new password to the mongod.log file in plain text.

Published

Date2026-06-09

Updated

Date2026-06-09

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://jira.mongodb.org/browse/SERVER-123370

CVE-2026-9750

SUMMARY

An authenticated user can cause a MongoDB server to crash or return incorrect results by creating documents that interfere with internal metadata processing during query execution. This stems from insufficient separation between user-controlled document fields and internal metadata in certain execution paths.

Published

Date2026-06-09

Updated

Date2026-06-09

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://jira.mongodb.org/browse/SERVER-123633

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…